Alpha-syntrophin deficiency protects against non-alcoholic steatohepatitis associated increase of macrophages, CD8+ T-cells and galectin-3 in the liver

Exp Mol Pathol. 2020 Apr:113:104363. doi: 10.1016/j.yexmp.2019.104363. Epub 2019 Dec 24.

Abstract

Non-alcoholic steatohepatitis (NASH) is characterized by immune cell infiltration. Loss of the scaffold protein alpha-syntrophin (SNTA) protected mice from hepatic inflammation in the methionine-choline-deficient (MCD) diet model. Here, we determined increased numbers of macrophages and CD8+ T-cells in MCD diet induced NASH liver of wild type mice. In the mutant animals these NASH associated changes in immune cell composition were less pronounced. Further, there were more γδ T-cells in the NASH liver of the null mice. Galectin-3 protein in the hepatic non-parenchymal cell fraction was strongly induced in MCD diet fed wild type but not mutant mice. Antioxidant enzymes declined in NASH liver with no differences between the genotypes. To identify the target cells responsive to SNTA loss in-vitro experiments were performed. In the human hepatic stellate cell line LX-2, SNTA did not regulate pro-fibrotic or antioxidant proteins like alpha-smooth muscle actin or catalase. Soluble galectin-3 was, however, reduced upon SNTA knock-down and increased upon SNTA overexpression. SNTA deficiency neither affected cell proliferation nor cell death of LX-2 cells. In the macrophage cell line RAW264.7 low SNTA indeed caused higher galectin-3 production whereas release of TNF and cell viability were normal. Moreover, SNTA had no effect on hepatocyte chemerin and CCL2 expression. Overall, SNTA loss improved NASH without causing major effects in macrophage, hepatocyte and hepatic stellate cell lines. SNTA null mice fed the MCD diet had less body weight loss and this seems to contribute to improved liver health of the mutant mice.

Keywords: CCL2; LX-2 cells; Lymphocytes; Proliferation; RAW264.7.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Antioxidants / metabolism
  • Body Weight
  • CD8-Positive T-Lymphocytes / immunology*
  • Calcium-Binding Proteins / deficiency*
  • Calcium-Binding Proteins / metabolism
  • Catalase / metabolism
  • Cell Line
  • Cell Proliferation
  • Cell Survival
  • Chemokine CCL2 / metabolism
  • Chemokines / metabolism
  • Connective Tissue Growth Factor / metabolism
  • Fatty Acid Synthases / metabolism
  • Feeding Behavior
  • Galectin 3 / metabolism*
  • Heme Oxygenase-1 / metabolism
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Interleukin-6 / metabolism
  • L-Lactate Dehydrogenase / metabolism
  • Liver / pathology*
  • Macrophages / metabolism
  • Macrophages / pathology*
  • Male
  • Membrane Proteins / deficiency*
  • Membrane Proteins / metabolism
  • Mice, Inbred C57BL
  • Muscle Proteins / deficiency*
  • Muscle Proteins / metabolism
  • Non-alcoholic Fatty Liver Disease / immunology*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Non-alcoholic Fatty Liver Disease / prevention & control*
  • Superoxide Dismutase / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Acta2 protein, mouse
  • Actins
  • Antioxidants
  • Calcium-Binding Proteins
  • Chemokine CCL2
  • Chemokines
  • Galectin 3
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-6
  • Membrane Proteins
  • Muscle Proteins
  • Tumor Necrosis Factor-alpha
  • chemerin protein, mouse
  • syntrophin alpha1
  • Connective Tissue Growth Factor
  • L-Lactate Dehydrogenase
  • Catalase
  • Heme Oxygenase-1
  • Superoxide Dismutase
  • Fatty Acid Synthases